Taltz (ixekizumab) is a prescription drug used to treat certain inflammatory conditions, including plaque psoriasis. This drug comes as a liquid solution that’s given as an injection under the skin.
INDIANAPOLIS, March 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application ...
INDIANAPOLIS, Aug. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Taltz® (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R ...
INDIANAPOLIS, Oct. 3, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented detailed data at the 5 th Annual Maui Derm NP+PA Fall meeting from the Phase 4 IXORA-R study, the first ...
The SPIRIT-H2H trial is the first completed large head-to-head or H2H superiority study in active PsA. This open-label, randomized, controlled trial is the first and only H2H study that utilizes ...
Taltz (ixekizumab) is a brand-name prescription drug that treats certain types of arthritis and psoriasis. The cost of Taltz with and without insurance can depend on several factors, such as whether ...